Feedback / Questions
tolimidone (MLR-1023) - Melior, Bukwang Pharma
https://www.businesswire.com/news/home/20200915005190/en/Melior-Pharmaceuticals-Awarded-Grant-for-Advancing-Pulmonary-Therapeutic-in-COVID-19-Phase-2-Clinical-Trial
Sep 15, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next